Westend Capital Management, LLC Bristol Myers Squibb CO Transaction History
Westend Capital Management, LLC
- $357 Billion
- Q4 2025
A detailed history of Westend Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Westend Capital Management, LLC holds 668 shares of BMY stock, worth $31,269. This represents 0.01% of its overall portfolio holdings.
Number of Shares
668
Previous 668
-0.0%
Holding current value
$31,269
Previous $30.1 Million
19.6%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,735Shares Held
1.58BCall Options Held
28.7MPut Options Held
28.6M-
Vanguard Group Inc Valley Forge, PA199MShares$9.3 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...